ARIX — Arix Bioscience Cashflow Statement
0.000.00%
Last trade - 00:00
- £183.80m
- £82.85m
- £0.11m
- 29
- 34
- 90
- 48
2018 December 31st | 2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 42.8 | -75.6 | 126 | -61.1 | -27.6 |
Depreciation | |||||
Non-Cash Items | -53.1 | 67.1 | -133 | 55.1 | 22.8 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -1.19 | -0.485 | 0.118 | -1.4 | -0.114 |
Change in Accounts Receivable | |||||
Change in Accounts Payable | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -11.1 | -8.47 | -6.73 | -7.14 | -4.64 |
Capital Expenditures | -0.002 | -0.006 | -0.007 | -0.101 | -0.008 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -115 | 34.1 | 66.3 | 42.1 | -12.8 |
Sale/Maturity of Investment | |||||
Change in Net Investments | |||||
Purchase of Investments | |||||
Cash from Investing Activities | -115 | 34.1 | 66.3 | 42 | -12.8 |
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 82.2 | -0.986 | 0 | -11.6 | -0.063 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -43.9 | 23.6 | 57.4 | 22.1 | -11.4 |